456 related articles for article (PubMed ID: 17983433)
1. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.
Cramer JA; Benedict A; Muszbek N; Keskinaslan A; Khan ZM
Int J Clin Pract; 2008 Jan; 62(1):76-87. PubMed ID: 17983433
[TBL] [Abstract][Full Text] [Related]
2. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
[TBL] [Abstract][Full Text] [Related]
3. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY
Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905
[TBL] [Abstract][Full Text] [Related]
4. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
[TBL] [Abstract][Full Text] [Related]
5. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.
Muszbek N; Brixner D; Benedict A; Keskinaslan A; Khan ZM
Int J Clin Pract; 2008 Feb; 62(2):338-51. PubMed ID: 18199282
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
[TBL] [Abstract][Full Text] [Related]
7. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE
J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215
[TBL] [Abstract][Full Text] [Related]
8. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
Baggarly SA; Kemp RJ; Wang X; Magoun AD
Res Social Adm Pharm; 2014; 10(6):e99-e112. PubMed ID: 24731547
[TBL] [Abstract][Full Text] [Related]
10. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
Calip GS; Elmore JG; Boudreau DM
Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
[TBL] [Abstract][Full Text] [Related]
11. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
[TBL] [Abstract][Full Text] [Related]
12. [Use of the EvalObs
Girerd X; Hanon O; Vaïsse B
Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508
[TBL] [Abstract][Full Text] [Related]
13. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta.
Ross LA; Bloodworth LS; Brown MA; Malinowski SS; Crane R; Sutton V; Karimi M; Dove Brown AC; Dobbs T; Hites L
Prev Chronic Dis; 2020 Sep; 17():E108. PubMed ID: 32945767
[TBL] [Abstract][Full Text] [Related]
14. A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications.
Alfian SD; Pradipta IS; Hak E; Denig P
J Clin Epidemiol; 2019 Apr; 108():44-53. PubMed ID: 30537541
[TBL] [Abstract][Full Text] [Related]
15. Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications.
Malo S; Aguilar-Palacio I; Feja C; Lallana MJ; Rabanaque MJ; Armesto J; Menditto E
Curr Med Res Opin; 2017 Jul; 33(7):1329-1336. PubMed ID: 28422521
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
[TBL] [Abstract][Full Text] [Related]
17. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
[TBL] [Abstract][Full Text] [Related]
18. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
[TBL] [Abstract][Full Text] [Related]
20. Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.
Karlsson SA; Hero C; Eliasson B; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Andersson Sundell K
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1220-1232. PubMed ID: 28799214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
